Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Journal of Nuclear Medicine

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • View or Listen to JNM Podcast
  • Visit JNM on Facebook
  • Join JNM on LinkedIn
  • Follow JNM on Twitter
  • Subscribe to our RSS feeds
Meeting ReportTechnologist Abstracts

Nuclear pharmacy compounding's impact on healthcare delivery

Julie Elliott
Journal of Nuclear Medicine May 2011, 52 (supplement 1) 2328;
Julie Elliott
1The PET Institute of Hampton Roads, Norfolk, VA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Info & Metrics
Loading

Abstract

2328

Objectives Nuclear Medicine clinicians are often uninformed about compounding in nuclear pharmacy. This "is a legal and accepted method of preparing customized medications, including radiopharmaceuticals, to meet unique physician identified patient needs," and fill supply gaps during times of product shortage.

Methods "Nuclear pharmacy compounding can be adding a radioactive liquid to a commercially available reagent kit, or the creation of a multi-component reagent kit or the synthesis of a radiolabeled compound via a multi-step preparation process. Compounding is different from manufacturing, which is guided by current good manufacturing practices (CGMP’s) [see United States Pharmacopeia (USP) <1078> Good Manufacturing Practices for Bulk Pharmaceutical Excipients (USPCI 1999i)] (2)." "Some of the characteristics or criteria that differentiate compounding from manufacturing include the existence of specific practitioner-patient-pharmacist relationships; the quantity of medication prepared in anticipation of receiving a valid prescription or prescription order; and the conditions of sale, which are limited to specific prescription orders."

Results Occasionally, a customized dose for a diagnostic test or treatment is needed. For example, a “physician may prescribe I-131 for treating thyroid cancer in a patient who requires a very small capsule to facilitate swallowing. A nuclear pharmacist can compound…” a small concentrated capsule to accommodate the needs of this patient. Recently, nuclear medicine departments have faced the challenge of keeping patient services available during severe isotope shortages. Nuclear pharmacists have bridged supply gaps by “…compounding radiopharmaceuticals from alternate isotope suppliers and making them available at the point of use.”

Conclusions Clinicians should be aware that this practice is an alternative for them to tailor services to patients and keep services available during times of chronic product shortages.

Research Support The Benefits of Nuclear Pharmacy Compounding. United Pharmacy Partners. Nuclear Compounding Guidelines. Radiopharmaceuticals in Nuclear Pharmacy and Nuclear Medicine

Back to top

In this issue

Journal of Nuclear Medicine
Vol. 52, Issue supplement 1
May 2011
  • Table of Contents
  • Index by author
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Journal of Nuclear Medicine.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Nuclear pharmacy compounding's impact on healthcare delivery
(Your Name) has sent you a message from Journal of Nuclear Medicine
(Your Name) thought you would like to see the Journal of Nuclear Medicine web site.
Citation Tools
Nuclear pharmacy compounding's impact on healthcare delivery
Julie Elliott
Journal of Nuclear Medicine May 2011, 52 (supplement 1) 2328;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Nuclear pharmacy compounding's impact on healthcare delivery
Julie Elliott
Journal of Nuclear Medicine May 2011, 52 (supplement 1) 2328;
Twitter logo Facebook logo LinkedIn logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One
Bookmark this article

Jump to section

  • Article
  • Info & Metrics

Related Articles

  • No related articles found.
  • Google Scholar

Cited By...

  • No citing articles found.
  • Google Scholar

More in this TOC Section

Technologist Abstracts

  • Effect of patient age, breast density, and topical anesthetic cream on perceived pain with sentinel lymph node scintigraphy
  • Molecular breast imaging: Can it adequately image breast tissue relative to mammography?
  • Automate tube current modulation variability with different scout and scan voltages (kV)
Show more Technologist Abstracts

Technologist Scientific Papers V

  • Effect of SPECT resolution on quantification of left ventricular volume and ejection fraction
  • Comparison of 4 different gamma cameras in pinhole collimator imaging of a thyroid phantom with I-131 and Tc-99m
  • Accuracy evaluation of CT-based attenuation correction in SPECT with different energy of radioisotopes
Show more Technologist Scientific Papers V

Similar Articles

SNMMI

© 2025 SNMMI

Powered by HighWire